tients with OTC deficiency (3 ) . This fact, together with the recent identification of deleterious mutations located deep within the introns of the OTC gene (4, 5 ) , demonstrates the need for new tools for mutation screening that include investigation of the noncoding regions of genes. Furthermore, for very large genes such as CPS1 (Ͼ120 kb encompassing 38 exons), being able to conduct a comprehensive analysis at the genomic DNA level without the need for numerous PCR amplifications of single exons could greatly simplify the search for disease-causing mutations. Finally, given that NAGS supplies the cofactor required for the CPS1-catalyzed reaction, biochemical measurements of intermediary metabolites cannot be used to distinguish between NAGS and CPS1 deficiencies (2 ) . Similarly, assays of biochemical markers can yield ambiguous results in late-onset forms of OTC deficiency (6 -8 ) . In such cases, the ability to simultaneously screen multiple genes potentially involved in a suspected metabolic disorder could avoid invasive procedures required for direct measurements of enzyme activity (9, 10 ) and thereby improve diagnostic efficiency.
With the development of next-generation sequencing (NGS) technologies, it is now possible to generate large amounts of sequence data at lower cost and with less effort (11 ) , offering new possibilities for diagnostic mutation screening (12) (13) (14) (15) (16) . To analyze specific regions in complex eukaryotic genomes with NGS, however, requires prior selection or amplification of the target regions. PCR, the most widely applied method for this purpose, has strong limitations in terms of multiplexing grade and product length that make it unsuitable for large or dispersed genomic targets. Therefore, hybridization to complementary oligonucleotide probes, either on DNA microarrays (17) (18) (19) or in solution (20 ) , has recently been successfully used to enrich genomic regions for NGS.
Given that the amount of sequence data that most NGS instruments generate in a full sequencing run is much larger than the amount required for reliable variant detection in moderately sized (200 kb) targets, analyzing multiple samples in parallel via the use of DNA bar codes might allow optimization of the costeffectiveness of this approach (13, 21 ) . The addition of a specific sequence tag (DNA bar code) to each sample enables pooled processing of samples (thereby reducing time and materials), as opposed to physical separation (e.g., sectoring of sequencing plates), which is also associated with a reduction in the total number of sequences generated (13, 21 ) .
Most microarray-based sequence capture (MSC) protocols have used high-density oligonucleotide arrays containing up to 385 000 capture probes to enrich genomic targets (18, 22 ) . We assessed the suitability of the use of medium-density arrays containing only 2240 oligonucleotide probes combined with a long-read NGS technology for MSC and the use of DNA bar codes for the parallel analysis of multiple samples. With inherited UCDs as a model, we investigated a 199-kb region that encompasses the complete genomic sequences of OTC, NAGS, and CPS1. This approach enabled (a) the detection of mutations not only in coding regions but also in regulatory and intronic regions, (b) the comprehensive investigation at the genomic DNA level of a large gene comprising many exons; and (c) the simultaneous investigation of 3 genes involved in the same disease pathway.
Materials and Methods

DNA SAMPLES
We analyzed a total of 4 DNA samples-2 samples taken from carriers of disease-causing OTC mutations (samples OTCA and OTCB) and 2 samples from CPS1-deficient patients (samples CPSA and CPSB). In all patients, the disease-associated mutations had previously been detected with Sanger sequencing. The patients or their parents provided informed consent for the genetic studies in this initial analysis. Subsequently, samples were irreversibly anonymized, and mutations were not known to the investigator. As a negative control, we also sequenced 1 sample without performing the MSC hybridization (sample UNC). We used DNA bar codes to analyze samples CPSA, CPSB, OTCB, and UNC, whereas we analyzed sample OTCA without bar codes by use of a sectored 454 picotiter plate in a comparison of both approaches.
ARRAY DESIGN AND SYNTHESIS
The target region encompassed the entire genomic regions of OTC, NAGS, and CPS1, along with 6 control loci for the assessment of enrichment efficacy (see Methods in the Data Supplement that accompanies the online version of this article at http://www. clinchem.org/content/vol57/issue1). Probes were designed by tiling the target regions with probes of 50 -60 bp, which were selected on the basis of melting temperature (T m ), complexity, secondary structure, GC content, and specificity. We ultimately used a total of 2240 capture probes resulting in a mean tiling density of 1 probe per 91 bp. There was no probe redundancy in the final array design. The Methods section in the online Data Supplement provides a more detailed description of the probe design. Arrays containing 4 independent 2240-feature microarrays on a single slide were synthesized on a CustomArray Synthesizer (CombiMatrix).
SAMPLE PREPARATION AND MSC HYBRIDIZATION
The Methods section in the online Data Supplement provides a detailed description of sample preparation and array hybridization procedures. In brief, 20 g of whole genome-amplified DNA was fragmented by nebulization to fragments of approximately 500 -600 bp, blunt-ended, and ligated to universal adaptors. The adaptor-ligated DNA was hybridized for 64 h at 42°C to one of 4 independent array sectors for samples CPSA, CPSB, and OTCB with hybridization conditions that were slightly modified compared with those for sample OTCA (see Methods in the online Data Supplement). We washed the hybridized arrays, eluted the captured DNA with molecular-grade water at 95°C, and amplified the DNA with the universal adaptors as primers. For DNA bar coding of samples CPSA, CPSB, OTCB, and UNC, we used primers containing a sample-specific 6-bp sequence tag (21 ) at the 5Ј end. We assessed enrichment success by using real-time quantitative PCR of the control loci and comparing samples taken before and after hybridization (see Methods in the online Data Supplement).
SEQUENCING AND DATA ANALYSIS
A 454-sequencing service provider (Microsynth) prepared a single sequencing library from the tagged and equally pooled samples CPSA, CPSB, OTCB, and UNC, and a separate library for sample OTCA. The libraries were analyzed on a 454 Genome Sequencer FLX Titanium (Roche) with half a picotiter plate for the pooled library and one-eighth of a plate for sample OTCA. We sorted sequence reads by bar code as described in the online Data Supplement and mapped them to the human genome and target regions with GS Reference Mapper (Roche Applied Sciences) and MOSAIK assembler software (23 ) . Only reads with a unique match to a chromosome containing a target gene were used for mapping to the target sequence. Statistical analyses were performed with the statistics software R (24 ) . A detailed description of these analyses is given in the Methods in the online Data Supplement.
Results
ENRICHMENT AND 454 SEQUENCING OF CAPTURED SAMPLES
The degree of enrichment for the captured samples was estimated by quantitative PCR analysis to be between 1489-fold and 3023-fold, indicating that MSC hybridization was successful (Table 1) . For the pooled library of samples CPSA, CPSB, OTCB, and UNC, we obtained a total of 584 390 sequence reads and 181 Mb of sequence with a mean read length of 311 bp. Of these sequence reads, 524 378 (90%) could be assigned unambiguously to one of the samples with aid of the DNA bar codes. The remaining sequence reads were either not assigned to any sample or assigned to multiple samples because of sequencing or synthesis errors in the bar code; these reads were therefore removed from the analysis. All 4 samples were represented with very similar proportions of sequence reads (range, 21%-25%), with at least 119 664 reads obtained per sample (Fig. 1B) .
For the individually sequenced sample OTCA, we obtained 91 688 sequence reads (20 Mb) with a mean read length of 219 bp. For the samples from the pooled library, 89% of all sequence reads had a unique match in the human genome, whereas this proportion was only 58% for sample OTCA (Table 1 and online Table  1 ). Of all reads with a unique match to a target chromosome, between 9225 and 12 712 reads (corresponding to Ͼ2.8 Mb of sequence per sample) were mapped to the target region with Ն95% sequence identity (Table 1) in the MSC-enriched samples, whereas only 202 reads (64 707 bp) were mapped in sample UNC.
In the MSC-enriched samples, Ն90% of the target region was covered by at least 1 sequence read at a median sequencing depth of 8-to 14-fold (Table 1, Fig.  1A ). Sequence coverage and median sequencing depth were lowest in sample OTCA, despite this sample having a similar overall number of mapped base pairs (Table 1, Fig. 1 ). This result indicated a more homogeneous sequence distribution across the target region for samples CPSA, CPSB, and OTCB, potentially because of the slightly modified hybridization protocol (Table 1) . Sample OTCB had the highest sequence coverage and sequencing depth and also had the highest estimated enrichment (Table 1) . In this sample, 79.8% of the target sequence had a sequencing depth of Ն5-fold, and 64.3% was sequenced at a depth of Ն10-fold (Table 2) .
INTERSAMPLE REPRODUCIBILITY
The 3 samples captured with an identical protocol (CPSA, CPSB, and OTCB) had very similar distributions of sequencing depth, which demonstrated the 
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high intersample reproducibility of the MSC procedure (Table 2, Fig. 2 ). The 3 samples had correlation coefficients for sequencing depth that ranged from 0.84 to 0.86 (see Table 2 in the online Data Supplement), and 82.6% of the nucleotide positions in the target sequence with a sequencing depth Ն10-fold in the leastenriched sample (CPSB) were sequenced at the same depth or greater in the other samples (Table 2) .
DIFFERENCES IN ENRICHMENT BETWEEN THE 3 TARGET GENES
The target genes had similar sequence coverages, but NAGS had the lowest median sequencing depth, indicating a less successful enrichment for this gene ( Table  1) . Comparison of the capture probes for the target genes revealed that NAGS probes had, on average, a higher GC content, a shorter length, a higher T m , and a lower tiling density than probes for OTC or CPS1 (see Table 3 in the online Data Supplement), suggesting that NAGS has sequence properties that are more challenging for MSC and NGS.
Furthermore, we observed that OTC had a lower median sequencing depth than CPS1 in sample CPSA. Because sample CPSA was the only sample from a male patient, the lower sequencing depth in the OTC gene can be explained by the patient's hemizygosity for this X-linked gene.
NONSPECIFIC SEQUENCE MAPPING
The amount of sequence mapped to the target regions was inversely correlated with the proximity to a capture probe in the MSC-enriched samples; however, no such correlation was observed in sample UNC, a finding that demonstrates the specificity of the MSC approach (Fig. 3A) . In the MSC-enriched samples, Ͼ91% of the mapped sequence data aligned on or within 100 bp of a capture probe, whereas in sample UNC, a large proportion (42%) of the aligned sequences mapped to regions with no capture probe within 100 bp (Fig. 3A) . A majority (94%) of these sequences mapped to a specific section of approximately 1800 bp in CPS1, a region for which no capture probes had been designed (Fig. 3B) . We had rejected all probes tested for this region because of substantial similarities with multiple other regions in the human genome (Fig. 3B) . This finding suggests that the sequences aligning to this section were not captured by MSC but were wrongly aligned from other genomic regions because of the high sequence similarity.
MUTATION DETECTION IN MSC-ENRICHED TARGET REGIONS
All OTC, NAGS, and CPS1 exons with flanking intronic and untranslated regions were screened for potential sequence variants, and parts of these screened regions were resequenced with Sanger technology (see Table 4 in the online Data Supplement). With both technologies, we sequenced a total of approximately 34 kb, of Overlap as the percentage of the minimum number of base pairs sequenced at a given depth across the investigated samples.
which 20 kb was covered Ն10-fold in the NGS analysis and 27 kb was sequenced at a coverage of Ն5-fold (Table 3). We correctly identified the previously detected disease-associated mutations in all 4 samples, including 4 heterozygous substitutions, 1 homozygous substitution, and 1 heterozygous 3-bp deletion (see Table 5 in the online Data Supplement). For heterozygote calling, we assessed 2 different cutoffs for the proportion of variant alleles observed in the NGS data (Table 3) . For both cutoffs, most (Ͼ87%) of the detected sequence variants in regions with a sequencing depth Ն10-fold were confirmed with Sanger technology, with the more stringent cutoff (cutoff B) producing an increased positive predictive value but a reduced sensitivity (Table  3) . Overall accuracy tended to be increased when the sequencing-depth threshold was increased, although the total number of variants assessed at higher depths was too small for reliable statistical inference. In regions with a sequencing depth between 5-fold and 9-fold, we observed a higher error rate for heterozygous, but not for homozygous, variants (Table 3) . Finally, 57 (92%) of 62 positions deviating from the reference sequence at a depth of Ն10-fold, which were not analyzed with Sanger sequencing, had a dbSNP record (25 ), a result again indicating a low false-positive rate for the NGS data. Insertions or deletions in or close to homopolymer regions of Ն4 repeats of the same base, a threshold selected by visual inspection of the sequencing data, were not considered in all analyses. In such regions, we confirmed only 2 of 10 putative variants with Sanger sequencing, indicating a high falsepositive rate.
Discussion
In this study, we successfully used medium-density oligonucleotide arrays for MSC and NGS and used sectored arrays and DNA bar coding to analyze multiple samples in parallel. Capturing the complete genomic regions of OTC, CPS1, and NAGS permitted the simultaneous and comprehensive screening for diseasecausing mutations in 3 genes involved in inborn UCDs. 
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MUTATION DETECTION IN MSC-ENRICHED TARGET REGIONS
We correctly identified all disease-causing mutations in the target genes in all samples. Furthermore, Sanger sequencing confirmed the majority of additional polymorphisms detected in the screened regions, a finding demonstrating the potential of this approach for mutation detection, given a sufficient sequencing depth. We obtained a high accuracy with a relatively low threshold depth (Ն10-fold) for variant detection. We also reliably detected homozygous variants at a depth of 5-fold to 9-fold, indicating that a lower threshold could potentially be used for hemizygous regions, such as X-linked genes in male patients. As demonstrated by the different cutoffs assessed for calling heterozygous variants, the threshold proportion of variant alleles also strongly influenced the sensitivity and specificity of mutation detection. A higher number of false positives was observed with a threshold of 20% variant alleles, whereas increasing this threshold to 30% produced a loss in sensitivity due to 1 undetected heterozygous mutation. Altogether, we observed only 1 false positive and 1 false negative in 19 615 analyzed base pairs at a 30% threshold and a sequencing depth of Ն10-fold (for a more detailed discussion, see the Supplementary Materials in the online Data Supplement). Diagnostic applications, however, require a higher threshold of sequencing depth to increase the accuracy of heterozygote calling (16 ) . Further refinement of standard thresholds and reliable estimation of error rates for mutation discovery with NGS requires the validation of larger numbers of putative variants with Sanger sequencing (14 ) . In the clinical setting, confirmation of putative diseaseassociated mutations with Sanger sequencing is thus strongly advisable until these standards become established. In this context, consideration also needs to be given to the increased overall number of sequence variants that will be detected when larger genomic regions are investigated (13 ) . Filtering strategies that identify known polymorphisms and predict potential functional effects are required to distinguish between potential disease-causing mutations and benign variants (26 ) .
DNA BAR CODING
We observed no reduction in sequence quality or increase in error rate due to the pooling of tagged samples, as indicated by the longer read lengths obtained for the bar-coded samples and the very low estimates of error rate for all samples. In contrast, compared with the individually analyzed sample OTCA, use of DNA bar codes yielded a Ͼ30% increase in the number of sequence reads per sample, which reduced the cost per nucleotide sequenced. Furthermore, only a single sequencing library needed to be prepared for 4 samples.
Having only a single library preparation substantially reduced the costs for library preparation and thus significantly improved the cost-effectiveness of the MSC/ NGS approach. In the future, with the continuing increase in read lengths of NGS technologies and the upcoming third-generation instruments promising even longer sequence reads (27 ) , parallel analyses of larger numbers of samples will become possible, because each sample will require fewer reads for sufficient coverage.
REDUCED TILING DENSITY AND THE ADVANTAGE OF LONG READ LENGTHS
Our use in this study of a single MSC hybridization to an oligonucleotide array containing only 2240 capture probes produced enrichment efficacies similar to those obtained with protocols that used Ͼ100-fold more probes or that used 2 successive MSC hybridizations for a similarly sized target (12, 18, 22, 28, 29 ) . Our results have thus demonstrated the suitability of this approach for capturing moderately sized targets (approximately 200 kb). Despite the low tiling density, our protocol also yielded enrichment uniformities similar to those reported for other studies (12, 18, 22, 28, 29 ) . Further studies are required, however, to determine the upper limit of MSC target size with such a low probe number. This successful enrichment with a much lower tiling density may be explained by the higher binding capacity of capture probes to the different array surface we used, compared with other oligonucleotide arrays (see discussion in the Supplementary Materials in the online Data Supplement). Besides platform-specific issues, which require experimental validation, reduced tiling densities may represent a platform-independent approach to efficiently capture long templates for NGS technologies that generate long sequence reads. Because of their lower diffusion rates and increased intramolecular base pairing, the hybridization of long DNA fragments to capture probes is expected to be inferior to that of short fragments (30 ) . Use of a high tiling density for target enrichment may therefore produce a general bias toward shorter captured fragments, reducing the overall sequence read length. Although a more controlled DNA-fragmentation process may overcome this bias in part, one can expect that a smaller number of short fragments will overlap with capture probes at a lower tiling density. This feature has the potential to reduce this bias and enable more longer fragments to be captured and sequenced. Comparative investigations with other target-enrichment systems are needed, however, to address this issue in more detail.
The possibility of obtaining long sequence reads may be of particular advantage for diagnostic applications. In addition to the less computationally intensive alignment procedure and a higher sensitivity for detecting larger insertions or deletions (12 ) , the use of a long-read NGS technology improves the direct observation of haplotype structures, because each NGS read displays the gametic phase directly. Longer read lengths produce longer stretches of known gametic phase, simplifying haplotype inference and thus providing valuable information for diagnostic applications (31 ) .
TARGET SEQUENCE PROPERTIES AND NONSPECIFIC MAPPING
Despite the strong overall enrichment we observed in this study, enrichment efficacy varied, depending on the genomic target. We observed only moderate enrichment for the NAGS gene. In agreement with other studies [e.g., (16, 20, 31 ) ], this finding indicates that MSC is more challenging in regions with unfavorable target sequence properties (e.g., high GC content). Furthermore, the amplification bias for the same regions during the whole genome-amplification process used for this protocol may have exacerbated this effect. At present, however, this amplification step may be unavoidable in the clinical setting, where often only small amounts of patient DNA are obtainable. Further optimization of the criteria used for probe design may improve enrichment in such regions, however. Moreover, including multiple probe replicates on an array or locally increasing the tiling density for problematic regions may compensate for a poorer enrichment or potential amplification bias and thus improve enrichment. Finally, further refinement of the enrichment procedure may also improve capture efficiency in such regions (32 ) .
Interestingly, a substantial amount of sequences in the uncaptured sample UNC mapped to a segment in the target sequence that contained no capture probes because of high sequence similarities to multiple other regions in the genome. This finding is surprising because only sequence reads with a unique match to the target chromosomes were used in the analysis, and it indicates that genomic regions with many highly homologous sequences present a challenge for NGS mapping algorithms. Because the sequencing depth in sample UNC in this region was above the threshold used for mutation detection, such nonspecific mapping represents a potential source of false positives in a mutation screening (12 ) . Further refinement of mapping algorithms is required to permit discrimination between such highly similar sequences (12 ) .
Conclusions
Our results highlight the potential of MSC combined with NGS for diagnostic mutation screening, as we have demonstrated for inherited UCDs. The use of sectored arrays and the use of DNA bar codes are independent possibilities for increasing throughput and reducing analysis costs. This approach not only enables the simultaneous and comprehensive investigation of multiple target genes but also facilitates the analysis of multiple samples in parallel, greatly simplifying the search for disease-causing mutations. Finally, the ability to investigate complete coding, intronic, and untranslated regions creates an opportunity to increase our knowledge of genetic variation in noncoding gene regions and its relevance for inherited disorders. 
